Opko Health OPK
NASDAQ OPK
$1.73 +0.04 (+2.41%)
As of: Sep 22, 2026 · 10:07 AM EDT

Opko Health (OPK) Income from Non-Controlling Interests (2012 - 2024)

Opko Health's (OPK) quarterly Income from Non-Controlling Interests came in at $600000.0 in Q1 2024, down 14.29% on a YoY basis from $700000.0 in Q2 2023, and down 14.29% quarter-over-quarter from $700000.0 in Q4 2023.

Analysis

Opko Health (OPK) Income from Non-Controlling Interests (2012 - 2024) Analysis & Trends

Opko Health (OPK) has reported Income from Non-Controlling Interests for 7 consecutive years, with $600000.0 the latest figure, recorded in Q1 2024.

  • For the quarter ending Q1 2024, Income from Non-Controlling Interests fell 14.29% year-over-year to $600000.0; the trailing twelve-month figure through Mar 2024 stood at $2.8 million (up 86.67% YoY), and the FY2025 full-year result was -$2.0 million, changed N/A from the prior year.
  • Income from Non-Controlling Interests slipped to $600000.0 in Q1 2024 per OPK's latest filing, from $700000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $800000.0 in Q3 2023 and bottomed at $100000.0 in Q3 2022.
  • Historically, Income from Non-Controlling Interests has averaged $614285.7 across 3 years, with a median of $700000.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Income from Non-Controlling Interests surged 700.0% in 2023, then decreased 14.29% in 2024.
  • Over 3 years, Income from Non-Controlling Interests stood at $700000.0 in 2022, then changed by 0.0% to $700000.0 in 2023, then dropped by 14.29% to $600000.0 in 2024.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $600000.0, $700000.0, and $800000.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 3.00 Mn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -2.00 Mn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -7.00 Mn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 10.00 Mn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -1.00 Mn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 39.52 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 600,000.00
Dec 31, 2023 700,000.00
Sep 30, 2023 800,000.00
Jun 30, 2023 700,000.00
Mar 31, 2023 700,000.00
Dec 31, 2022 700,000.00
Sep 30, 2022 100,000.00
Jun 30, 2015 -475,000.00
Mar 31, 2015 -925,000.00
Dec 31, 2014 -491,000.00
Sep 30, 2014 -1.35 Mn
Jun 30, 2014 -597,000.00
Mar 31, 2014 -540,000.00
Dec 31, 2013 -630,000.00
Sep 30, 2013 -803,000.00
Jun 30, 2013 -959,000.00
Mar 31, 2013 -547,000.00
Dec 31, 2012 -492,000.00
API Access

Opko Health Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=OPK&period=max&api_key=YOUR_API_KEY